Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Cytokine-induced differentiation of multipotent adult progenitor cells into functional smooth muscle cells
Jeffrey J. Ross, … , Robert T. Tranquillo, Catherine M. Verfaillie
Jeffrey J. Ross, … , Robert T. Tranquillo, Catherine M. Verfaillie
Published December 1, 2006
Citation Information: J Clin Invest. 2006;116(12):3139-3149. https://doi.org/10.1172/JCI28184.
View: Text | PDF | Corrigendum
Research Article

Cytokine-induced differentiation of multipotent adult progenitor cells into functional smooth muscle cells

  • Text
  • PDF
Abstract

Smooth muscle formation and function are critical in development and postnatal life. Hence, studies aimed at better understanding SMC differentiation are of great importance. Here, we report that multipotent adult progenitor cells (MAPCs) isolated from rat, murine, porcine, and human bone marrow demonstrate the potential to differentiate into cells with an SMC-like phenotype and function. TGF-β1 alone or combined with PDGF-BB in serum-free medium induces a temporally correct expression of transcripts and proteins consistent with smooth muscle development. Furthermore, SMCs derived from MAPCs (MAPC-SMCs) demonstrated functional L-type calcium channels. MAPC-SMCs entrapped in fibrin vascular molds became circumferentially aligned and generated force in response to KCl, the L-type channel opener FPL64176, or the SMC agonists 5-HT and ET-1, and exhibited complete relaxation in response to the Rho-kinase inhibitor Y-27632. Cyclic distention (5% circumferential strain) for 3 weeks increased responses by 2- to 3-fold, consistent with what occurred in neonatal SMCs. These results provide evidence that MAPC-SMCs are phenotypically and functionally similar to neonatal SMCs and that the in vitro MAPC-SMC differentiation system may be an ideal model for the study of SMC development. Moreover, MAPC-SMCs may lend themselves to tissue engineering applications.

Authors

Jeffrey J. Ross, Zhigang Hong, Ben Willenbring, Lepeng Zeng, Brett Isenberg, Eu Han Lee, Morayma Reyes, Susan A. Keirstead, E. Kenneth Weir, Robert T. Tranquillo, Catherine M. Verfaillie

×

Figure 4

Expression of genes encoding structural proteins, transcription factors, and ECM transcripts in F-MAPCs.

Options: View larger image (or click on image) Download as PowerPoint
Expression of genes encoding structural proteins, transcription factors,...
(A) Expression levels of α-SMA, SM22α, calponin, SM-MHC, and smoothelin, expressed as percentage of RAOSMC expression, significantly increased from day 0 to day 6 (P < 0.01; n = 6) and further increased to levels similar to those in RAOSMCs by passage 1 (P < 0.01; n = 6), with the exception of SM-MHC. (B) Low levels of the SMC transcription factors myocardin and Gata-6 were present at day 0 and increased by day 6 and passage 1. (C) Expression of the preferentially expressed VSMC transcript SmLim/CPP-2 was greater than that observed in RAOSMCs. Collagen type I and III mRNAs were expressed at levels similar to those in RAOSMCs by day 6 and further increased by passage 1 (n = 6). (D) Day 6 and passage 1 expression levels of telokin and γ-actin mRNA are similar to those in RAOSMCs and significantly lower than in visceral RUSMCs (P < 0.01; n = 6).

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts